Overview of the Transaction
On October 3, 2023, Saba Capital Management, L.P. (Trades, Portfolio), a New York-based investment firm, reduced its stake in Mfs Investment Grade Municipal Trust (NYSE:CXH). The firm sold 4,203 shares at a trade price of $7.02, resulting in a trade change of -0.46. Despite this reduction, Saba Capital still holds a significant position in the company, with 908,783 shares, representing 9.98% of their portfolio.
Profile of Saba Capital Management, L.P. (Trades, Portfolio)
Saba Capital Management, L.P. (Trades, Portfolio), located at 405 Lexington Avenue, New York, NY 10174, is a renowned investment firm. The firm manages an equity portfolio worth $3.84 billion, spread across 624 stocks. Its top holdings include Templeton Global Income Fund(NYSE:GIM), BlackRock Capital Allocation Trust(NYSE:BCAT), BlackRock Health Sciences Trust II(NYSE:BMEZ), BlackRock Innovation & Growth Tr(NYSE:BIGZ), and BlackRock ESG Capital Allocation Trust(NYSE:ECAT). The firm's investments are primarily concentrated in the Financial Services and Technology sectors.
Insight into Mfs Investment Grade Municipal Trust
Mfs Investment Grade Municipal Trust (NYSE:CXH) is a diversified closed-end management investment company based in the USA. The company's primary objective is to seek high current income exempt from federal income tax, with a secondary consideration for capital appreciation. The company invests a majority of its net assets in tax-exempt bonds and tax-exempt notes. With a market capitalization of $62.952 million, the company's stock is currently priced at $6.91. However, the GF Value suggests a fair value of $13.80, indicating that the stock might be undervalued. The GF-Score of 58/100 suggests a poor future performance potential.
Guru's Position in the Traded Stock
Despite the recent reduction, Saba Capital Management, L.P. (Trades, Portfolio) still holds a significant position in Mfs Investment Grade Municipal Trust. The 908,783 shares held by the firm represent 0.17% of their portfolio. This indicates the firm's continued confidence in the stock, despite its recent performance.
Performance and Financial Health of the Traded Stock
Since the transaction, the stock has experienced a -1.57% change in price. The stock's year-to-date price change ratio stands at -3.89. The company's financial strength, as indicated by its balance sheet rank of 4/10 and profitability rank of 2/10, suggests room for improvement. The company's Piotroski F-Score of 3 further underscores this point.